Vmn2r22 activators are a class of compounds that are understood to engage with the Vmn2r22 receptor, a G-protein coupled receptor found within the vomeronasal organ of certain animals. These activators are characterized by their ability to bind to and activate the Vmn2r22 receptor, triggering a series of cellular responses integral to the detection of pheromonal cues. Upon activation, the typical response involves the modulation of intracellular second messengers like cAMP or calcium ions, which are pivotal in the transduction of signals from the external environment to the internal cellular machinery. The precise molecular interaction between the Vmn2r22 activators and the receptor is critical; it initiates the signal transduction processes that govern the cellular responses to pheromonal signals.
The chemical activators of Vmn2r22 influence various stages of the receptor's signaling pathway. Some compounds can increase the concentration of intracellular cAMP by activating adenylyl cyclase or inhibiting phosphodiesterases, thus amplifying the signaling cascade initiated by the receptor. Others can modulate the calcium ion concentration within cells through various mechanisms, such as chelation, or by affecting the transport of calcium ions across cellular compartments, thus influencing the signal transduction pathways associated with Vmn2r22. Inhibition of G-proteins and their signaling pathways is also a method by which these activators can alter the function of the receptor. These activators play a crucial role in the modulation of the cellular processes that follow receptor activation, which are essential for the organism's response to its environment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, could prevent cAMP breakdown, which could possibly activate Vmn2r22 by enhancing signaling through pathways it is associated with. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Cell-permeant calcium chelator, could modulate intracellular calcium levels which could possibly activate Vmn2r22 by altering signal transduction. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), could increase cytosolic calcium concentration, which could possibly activate Vmn2r22 through altered calcium signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore, can increase intracellular calcium, which could possibly activate Vmn2r22 by mimicking the action of calcium-mobilizing ligands. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inhibits G-proteins, could alter signaling through Vmn2r22 by modulating G-protein activity, which could possibly lead to its activation. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Inhibitor of protein kinase C, could affect signaling pathways and could possibly activate Vmn2r22 by modulating downstream effects of its activation. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Protein kinase C inhibitor, could modulate signaling pathways and could possibly activate Vmn2r22 by interfering with downstream signal transduction. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor, could affect phosphorylation events and could possibly activate Vmn2r22 by altering signaling dynamics. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibitor of Ca2+/calmodulin-dependent protein kinase II, could modulate signaling pathways and could possibly activate Vmn2r22 through changes in calcium-dependent signaling. | ||||||